Stern, Jennifer I.
Robertson, Carrie E.
Article History
Accepted: 25 October 2023
First Online: 11 December 2023
Compliance with Ethical Standards
:
: Jennifer I. Stern, MD, is a shareholder in Emmyon, a biotechnology company that has no relevance to any topic in this manuscript. Carrie E. Robertson, MD, has previously served on advisory boards for Lundbeck, Biohaven, Impel, Linpharma, and Satsuma. She has received research support from Teva, Pfizer, and Lundbeck, with funds paid to her institution. She also receives royalties as author and section editor for UpToDate.
: This article does not contain any studies with human or animal subjects performed by any of the authors.